Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis.

Berger, Christopher A; Alipanah, Narges; Kheir, Fayez; Ruminjo, Joseph K; Nahid, Payam; Thomson, Carey

Berger, Christopher A; Alipanah, Narges; Kheir, Fayez; Ruminjo, Joseph K; Nahid, Payam; Thomson, Carey.

Affiliation

Berger CA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCSF Center for Tuberculosis, University of California, San Francisco, California.
Alipanah N; Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCSF Center for Tuberculosis, University of California, San Francisco, California.
Kheir F; Tulane University School of Medicine, New Orleans, Louisiana.
Ruminjo JK; American Thoracic Society, New York, New York.
Nahid P; Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCSF Center for Tuberculosis, University of California, San Francisco, California.
Thomson C; Division of Pulmonary and Critical Care, Department of Medicine, Mount Auburn Hospital, Cambridge, Massachusetts; and.

Ann Am Thorac Soc ; 17(8): 911-917, 2020 08.

Article de En | MEDLINE | ID: mdl-32464069

Sujet(s)
Mots clés

MDR-TB; drug treatment; duration of treatment; treatment monitoring; tuberculosis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tuberculose pulmonaire / Tuberculose multirésistante / Antituberculeux Type d'étude: Guideline Limites: Humans Langue: En Journal: Ann Am Thorac Soc Année: 2020 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google